Ge Long Hui·2025-11-11 12:43Core Viewpoint - China National Pharmaceutical Group (01880.HK) announced that its A-share stock experienced a cumulative price fluctuation exceeding 20% over three consecutive trading days from November 7 to November 11, 2025, which is classified as an abnormal trading situation according to the Shanghai Stock Exchange regulations [1] Summary by Relevant Sections - Stock Price Fluctuation The company's A-share stock saw a cumulative price increase deviation of over 20% during the specified trading days [1] - Self-Examination and Disclosure Following a self-examination and written inquiry to its controlling shareholder, the company confirmed that there are no undisclosed significant matters or risk issues as of the date of this announcement [1] - Investor Advisory The company urges investors to be aware of secondary market trading risks and to make rational decisions and cautious investments [1]